1,176 reports of this reaction
3.3% of all ZIPRASIDONE reports
#2 most reported adverse reaction
WEIGHT INCREASED is the #2 most commonly reported adverse reaction for ZIPRASIDONE, manufactured by ROERIG. There are 1,176 FDA adverse event reports linking ZIPRASIDONE to WEIGHT INCREASED. This represents approximately 3.3% of all 36,171 adverse event reports for this drug.
Patients taking ZIPRASIDONE who experience weight increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT INCREASED is moderately reported among ZIPRASIDONE users, representing a notable but not dominant share of adverse events.
In addition to weight increased, the following adverse reactions have been reported for ZIPRASIDONE:
The following drugs have also been linked to weight increased in FDA adverse event reports:
WEIGHT INCREASED has been reported as an adverse event in 1,176 FDA reports for ZIPRASIDONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT INCREASED accounts for approximately 3.3% of all adverse event reports for ZIPRASIDONE, making it one of the most commonly reported side effect.
If you experience weight increased while taking ZIPRASIDONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.